ArticleFrontiers in immunology2023
Targeting NETs using dual-active DNase1 variants.
Hanna Englert et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papercites it
ArticleFrontiers in immunology2023
Hanna Englert et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.